Patents by Inventor Ramesh Matioram Gidwani

Ramesh Matioram Gidwani has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 9012464
    Abstract: Afatinib salts and crystalline forms thereof are described in the present application and processes for their preparation. Crystalline forms of Afatinib are also described in the present application and processes for their preparation. The present invention also includes pharmaceutical compositions of such Afatinib salts and crystalline forms thereof or crystalline forms of Afatinib, methods of their preparation and the use thereof in the treatment of a patient in need thereof.
    Type: Grant
    Filed: November 23, 2011
    Date of Patent: April 21, 2015
    Assignee: Ratiopharm GmbH
    Inventors: Ramesh Matioram Gidwani, Channaveerayya Hiremath, Manoj Dalsingar Yadav, Wolfgang Albrecht, Dirk Fischer
  • Patent number: 8946482
    Abstract: The present invention relates to salts of rasagiline and pharmaceutical preparations thereof. The invention further provides a method of preparing the salts of rasagiline.
    Type: Grant
    Filed: July 7, 2010
    Date of Patent: February 3, 2015
    Assignee: Ratiopharm GmbH
    Inventors: Thomas Thyrann, Christian Janssen, Ramesh Matioram Gidwani
  • Publication number: 20140357860
    Abstract: The present invention relates to pharmaceutical compositions with delayed release which contain ivabradine adipate as active substance. The present invention furthermore relates to processes for the preparation of this composition and certain salts of ivabradine.
    Type: Application
    Filed: August 19, 2014
    Publication date: December 4, 2014
    Applicant: ratiopharm GmbH
    Inventors: Ramesh Matioram GIDWANI, Mayur Vilas KOLHATKAR, Dominique MEERGANS, Ralph STEFAN, Jens GEIER
  • Patent number: 8766005
    Abstract: The invention relates to a process for producing pharmaceutically acceptable salts of fingolimod (I), comprising the step of reacting N-[1,1-bis hydroxymethyl-3-(4-octyl phenyl)-propyl]-acylamide (II) with an acidic compound. Furthermore, the invention provides different pharmaceutically acceptable salts of fingolimod and a polymorphic form of fingolimod hydrochloride.
    Type: Grant
    Filed: July 23, 2010
    Date of Patent: July 1, 2014
    Assignee: Ratiopharm GmbH
    Inventors: Ramesh Matioram Gidwani, Channaveerayya Hiremath
  • Publication number: 20140051713
    Abstract: Afatinib salts and crystalline forms thereof are described in the present application and processes for their preparation. Crystalline forms of Afatinib are also described in the present application and processes for their preparation. The present invention also includes pharmaceutical compositions of such Afatinib salts and crystalline forms thereof or crystalline forms of Afatinib, methods of their preparation and the use thereof in the treatment of a patient in need thereof.
    Type: Application
    Filed: November 23, 2011
    Publication date: February 20, 2014
    Inventors: Ramesh Matioram Gidwani, Channaveerayya Hiremath, Manoj Dalsingar Yadav, Wolfgang Albrecht, Dirk Fischer
  • Publication number: 20130116239
    Abstract: The present invention relates to pharmaceutical compositions with delayed release which contain ivabradine adipate as active substance. The present invention furthermore relates to processes for the preparation of this composition and certain salts of ivabradine.
    Type: Application
    Filed: June 14, 2011
    Publication date: May 9, 2013
    Applicant: ratiopharm GnbH
    Inventors: Ramesh Matioram Gidwani, Mayur Vilas Kolhatkar, Dominique Meergans, Ralph Stefan, Jens Geier
  • Publication number: 20120184617
    Abstract: The invention relates to a process for producing pharmaceutically acceptable salts of fingolimod (I), comprising the step of reacting N-[1,1-bis hydroxymethyl-3-(4-octyl phenyl)-propyl]-acylamide (II) with an acidic compound. Furthermore, the invention provides different pharmaceutically acceptable salts of fingolimod and a polymorphic form of fingolimod hydrochloride.
    Type: Application
    Filed: July 23, 2010
    Publication date: July 19, 2012
    Applicant: RATIOPHARM GMBH
    Inventors: Ramesh Matioram Gidwani, Channaveerayya Hiremath
  • Publication number: 20120142966
    Abstract: The present invention relates to salts of rasagiline and pharmaceutical preparations thereof. The invention further provides a method of preparing the salts of rasagiline.
    Type: Application
    Filed: July 7, 2010
    Publication date: June 7, 2012
    Inventors: Thomas Thyrann, Christian Janssen, Ramesh Matioram Gidwani